Literature DB >> 26604267

ADHD in the United Kingdom: Regional and Socioeconomic Variations in Incidence Rates Amongst Children and Adolescents (2004-2013).

Adrian J Hire1, Darren M Ashcroft1, David A Springate1, Douglas T Steinke1.   

Abstract

OBJECTIVE: To describe the incidence and distribution of ADHD within the United Kingdom, and to examine whether there was any association between ADHD incidence and socioeconomic deprivation.
METHOD: The study used data from the Clinical Practice Research Datalink (CPRD). Patients diagnosed with ADHD before the age of 19 between January 1, 2004 and December 31, 2013 were stratified according to the region in which their general practice was based. Practice Index of Multiple Deprivation (IMD) score was used as a surrogate measure of patients' deprivation status.
RESULTS: ADHD incidence was relatively stable between 2004 and 2013, but peaked in the last 2 years studied. Statistically significant ( p ≤ .05) differences in incidence were observed between U.K. regions. In almost every year studied, incidence rates were highest among the most deprived patients and lowest among the least deprived patients.
CONCLUSION: In the United Kingdom, ADHD may be associated with socioeconomic deprivation.

Entities:  

Keywords:  ADHD; deprivation; incidence; variation

Mesh:

Year:  2015        PMID: 26604267     DOI: 10.1177/1087054715613441

Source DB:  PubMed          Journal:  J Atten Disord        ISSN: 1087-0547            Impact factor:   3.256


  6 in total

1.  Prescribing trends of attention-deficit hyperactivity disorder (ADHD) medications in UK primary care, 1995-2015.

Authors:  Christel Renoux; Ju-Young Shin; Sophie Dell'Aniello; Emma Fergusson; Samy Suissa
Journal:  Br J Clin Pharmacol       Date:  2016-06-09       Impact factor: 4.335

2.  Sensitivity of the UK Clinical Practice Research Datalink to Detect Neurodevelopmental Effects of Medicine Exposure in Utero: Comparative Analysis of an Antiepileptic Drug-Exposed Cohort.

Authors:  R A Charlton; A McGrogan; J Snowball; L M Yates; A Wood; J Clayton-Smith; W H Smithson; J L Richardson; N McHugh; S H L Thomas; G A Baker; R Bromley
Journal:  Drug Saf       Date:  2017-05       Impact factor: 5.606

3.  Racial Disparities in Diagnosis of Attention-Deficit/Hyperactivity Disorder in a US National Birth Cohort.

Authors:  Yu Shi; Lindsay R Hunter Guevara; Hayley J Dykhoff; Lindsey R Sangaralingham; Sean Phelan; Michael J Zaccariello; David O Warner
Journal:  JAMA Netw Open       Date:  2021-03-01

4.  Incidence of Attention Deficit Hyperactivity Disorder (ADHD) Diagnoses in Navarre (Spain) from 2003 to 2019.

Authors:  Leire Leache; Olast Arrizibita; Marta Gutiérrez-Valencia; Luis Carlos Saiz; Juan Erviti; Julián Librero
Journal:  Int J Environ Res Public Health       Date:  2021-08-31       Impact factor: 3.390

5.  Completeness and representativeness of small area socioeconomic data linked with the UK Clinical Practice Research Datalink (CPRD).

Authors:  Preveina Mahadevan; Mia Harley; Stuart Fordyce; Susan Hodgson; Rebecca Ghosh; Puja Myles; Helen Booth; Eleanor Axson
Journal:  J Epidemiol Community Health       Date:  2022-07-28       Impact factor: 6.286

6.  Trends and regional variations in the administrative prevalence of attention-deficit/hyperactivity disorder among children and adolescents in Germany.

Authors:  M K Akmatov; A Steffen; J Holstiege; R Hering; M Schulz; J Bätzing
Journal:  Sci Rep       Date:  2018-11-19       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.